PHR Q2 2026

Q1 2027 Q4 2026 Q3 2026 Q2 2026

Earnings

Phreesia delivered a mixed fiscal second quarter for 2026, posting revenue of $117.25 million, up 14.8% year-over-year and edging past the $116.38 million consensus by 0.75%, while earnings came in far short of expectations, with GAAP diluted EPS of … Read more Phreesia delivered a mixed fiscal second quarter for 2026, posting revenue of $117.25 million, up 14.8% year-over-year and edging past the $116.38 million consensus by 0.75%, while earnings came in far short of expectations, with GAAP diluted EPS of $0.01 against a consensus of $0.19, a miss of 94.81%. The earnings shortfall, however, obscures a meaningful underlying shift: Phreesia swung to GAAP net income of $654,000 from a net loss of $18.01 million a year ago, driven by sharply improving operating leverage and a discrete deferred tax benefit. Adjusted EBITDA more than tripled to $22.13 million from $6.53 million in Q2 FY2025, reflecting disciplined cost controls including a $4.80 million reduction in sales and marketing expense. The quarter's headline strategic move was Phreesia's announced $160 million cash acquisition of AccessOne, a healthcare financing platform expected to add roughly $35 million in annualized revenue and expand the company's total addressable market by approximately $6 billion. Looking ahead, management raised its FY2026 Adjusted EBITDA guidance to $87 million to $92 million while maintaining its revenue outlook of $472 million to $482 million, with at least one analyst lifting their price target following the results.